ACADIAN ASSET MANAGEMENT LLC - KAZIA THERAPEUTICS LTD ownership

KAZIA THERAPEUTICS LTD's ticker is KZIA and the CUSIP is 48669G105. A total of 19 filers reported holding KAZIA THERAPEUTICS LTD in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of KAZIA THERAPEUTICS LTD
ValueSharesWeighting
Q4 2023$8
-55.6%
18,6820.0%0.00%
Q3 2023$18
-76.6%
18,682
-72.6%
0.00%
Q2 2023$77
+10.0%
68,2240.0%0.00%
Q1 2023$70
+9.4%
68,224
-34.5%
0.00%
Q4 2022$64
-100.0%
104,173
-37.8%
0.00%
-100.0%
Q3 2022$183,000
+2950.0%
167,387
+17594.2%
0.00%
Q3 2020$6,000
-25.0%
946
-60.3%
0.00%
Q3 2018$8,000
-66.7%
2,381
-70.6%
0.00%
Q2 2018$24,000
-46.7%
8,1010.0%0.00%
Q1 2018$45,0008,1010.00%
Other shareholders
KAZIA THERAPEUTICS LTD shareholders Q4 2023
NameSharesValueWeighting ↓
UBS Group AG 960$5,0000.00%
AdvisorNet Financial, Inc 5$00.00%
BREWIN DOLPHIN LTD 32$1800.00%
MORGAN STANLEY 50,001$281,0000.00%
ACADIAN ASSET MANAGEMENT LLC 8,101$45,0000.00%
Renaissance Technologies 34,325$193,0000.00%
ROYAL BANK OF CANADA 1,250$7,0000.00%
BANK OF AMERICA CORP /DE/ 5$00.00%
View complete list of KAZIA THERAPEUTICS LTD shareholders